tiprankstipranks
Advertisement
Advertisement

HK:4332 Stock Latest News

Amgen price target raised to $351 from $347 at Guggenheim
The FlyAmgen price target raised to $351 from $347 at Guggenheim
11h ago
AMGN
Amgen: Long-Term AI Potential but Limited Near-Term Upside Supports Hold Rating
PremiumRatings
Amgen: Long-Term AI Potential but Limited Near-Term Upside Supports Hold Rating
12h ago
AMGN
Amgen price target raised to $325 from $319 at Truist
PremiumThe Fly
Amgen price target raised to $325 from $319 at Truist
1d ago
AMGN
Viridian Therapeutics price target lowered to $36 from $40 at Truist
PremiumThe Fly
Viridian Therapeutics price target lowered to $36 from $40 at Truist
1d ago
AMGN
VRDN
Amgen price target raised to $325 from $319 at Truist
PremiumThe Fly
Amgen price target raised to $325 from $319 at Truist
1d ago
AMGN
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
PremiumThe FlyViridian Therapeutics price target lowered to $31 from $37 at Wedbush
1d ago
AMGN
VRDN
Amgen put volume heavy and directionally bearish
Premium
The Fly
Amgen put volume heavy and directionally bearish
2d ago
AMGN
Amgen price target raised to $370 from $360 at RBC Capital
Premium
The Fly
Amgen price target raised to $370 from $360 at RBC Capital
2d ago
AMGN
Leerink sees weakness in Viridian Therapeutics shares as ‘overdone’
PremiumThe Fly
Leerink sees weakness in Viridian Therapeutics shares as ‘overdone’
3d ago
AMGN
VRDN
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
PremiumThe Fly
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
3d ago
WW
AMC
Stifel sees path towards differentiation for Viridian after Amgen data
PremiumThe Fly
Stifel sees path towards differentiation for Viridian after Amgen data
3d ago
AMGN
VRDN
Amgen announces ‘positive’ results from Phase 3 trial of tepezza
PremiumThe Fly
Amgen announces ‘positive’ results from Phase 3 trial of tepezza
3d ago
AMGN
Evercore cuts Viridian price target, removes from ‘Tactical Outperform’ list
PremiumThe FlyEvercore cuts Viridian price target, removes from ‘Tactical Outperform’ list
7d ago
AMGN
VRDN
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
Premium
The Fly
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
8d ago
AMGN
ZLAB
FDA identifies cases of serious liver injury in patients taking Tavneos
Premium
The Fly
FDA identifies cases of serious liver injury in patients taking Tavneos
9d ago
AMGN
Amgen announces data on Repatha from Phase 3 Vesalius-CV trial
PremiumThe Fly
Amgen announces data on Repatha from Phase 3 Vesalius-CV trial
11d ago
AMGN
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
22d ago
AMGN
REGN
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $390 from $375 at Wells Fargo
22d ago
AMGN
REGN
Amgen initiated with a Hold at Jefferies
PremiumThe Fly
Amgen initiated with a Hold at Jefferies
1M ago
AMGN
Kyowa Kirin announces discontinuation of rocatinlimab clinical trials
PremiumThe FlyKyowa Kirin announces discontinuation of rocatinlimab clinical trials
1M ago
AMGN
Private Markets: World Labs raises $1B in new funding
Premium
The Fly
Private Markets: World Labs raises $1B in new funding
1M ago
U
BX
Amgen Prices $4 Billion Senior Unsecured Notes Offering
Premium
Company Announcements
Amgen Prices $4 Billion Senior Unsecured Notes Offering
2M ago
8K
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >